French decree on cytogenetic testing:
This article was originally published in Clinica
Prior authorisation from the government is needed for laboratories in France to perform cytogenetic testing antenatally or postnatally, including when they are being used as a means to determine the sex of a foetus or to determine whether an ultrasound follow-up is needed. That is the thrust of a decree published in the Journal officiel on November 30, which also sets out the levels at which these laboratories will be reimbursed for the tests. The decree also lays out the conditions under which reimbursement will be given.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.